Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 129, 2023 - Issue 2
146
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Inhibition of notch signalling and mesangial expansion by combined glucagon like peptide-1 agonist and crocin therapy in animal model of diabetic nephropathy

ORCID Icon, , , ORCID Icon &
Pages 544-554 | Received 28 Apr 2020, Accepted 26 Oct 2020, Published online: 07 Dec 2020

References

  • Abedimanesh, N., et al., 2020. Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF-κB, and MCP-1 in patients with coronary artery disease: a randomized placebo-controlled clinical trial. Phytotherapy research, 34 (5), 1114–1122. May Epub 2019 Dec 3. PMID: 31797473.
  • Adewole, S., et al., 2010. Effect of melatonin on carbon tetrachloride-induced kidney injury in Wistar rats. African journal of biomedical research, 10 (2), 153–164.
  • Altinoz, E., et al., 2015. Protective effects of saffron (its active constituent, crocin) on nephropathy in streptozotocin-induced diabetic rats. Human & experimental toxicology, 34 (2), 127–134.
  • Altman, G. D., 2005. Comparing groups: Three or more independent groups of observations in practical statistics for medical research. London: Chapman and Hall.
  • Arauz-Pacheco, C., Parrott, M.A., and Raskin, P., 2002. The treatment of hypertension in adult patients with diabetes. Diabetes care, 25 (1), 134–147.
  • Bahmani, F., et al., 2016. Inhibitory effect of crocin(s) on lens α-crystallin glycation and aggregation, results in the decrease of the risk of diabetic cataract. Molecules (Basel, Switzerland)), 21 (2), 143.
  • Balanescu, S., et al., 2011. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. The journal of clinical endocrinology and metabolism, 96 (4), 1046–1052.
  • Bancroft, J. D., and Gamble, M., 2008. Theory and practice of histological techniques. 6th ed. London: Churchill Livingstone, Elsevier.
  • Baylis, C., 2008. Nitric oxide deficiency in chronic kidney disease. American journal of physiology renal physiology, 294 (1), F1–F9.
  • Becker, R.H., et al., 2005. Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects. Experimental and clinical endocrinology & diabetes, 113 (8), 435–443.
  • Benedito, R., et al., 2012. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature, 18484 (7392), 110–114.
  • Bielesz, B., et al., 2010. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. The journal of clinical investigation, 120 (11), 4040–4054.
  • Billiard, F., et al., 2018. Delta-like ligand-4-notch signaling inhibition regulates pancreatic islet function and insulin secretion. Cell reports, 2322 (4), 895–904.
  • Boshra, V., and Elkashef, W., 2017. Renal insulin sensitizing effect of exenatide in a high-fat diet obesity rat model. British journal of medicine and medical research, 20 (6), 1–13.
  • Craven, P.A., Melhem, M.F., and DeRubertis, F.R., 1992. Thromboxane in the pathogenesis of glomerular injury in diabetes. Kidney international, 42 (4), 937–946.
  • Drucker, D.J., 2006. The biology of incretin hormones. Cell metabolism, 3 (3), 153–165.
  • Einbinder, Y., et al., 2016. Glucagon-like peptide-1 and vitamin D: anti-inflammatory response in diabetic kidney disease in db/db mice and in cultured endothelial cells. Diabetes/metabolism research and reviews, 32 (8), 805–815.
  • El-Gohary, O.A., and Said, M.A., 2016. Protective effect of exenatide (glucagon-like peptide-1 receptor agonist) on renal ischemia–reperfusion injury in diabetic rats. Benha medical journal, 33 (1), 24.
  • Fatehi, M., Rashidabady, T., and Fatehi-Hassanabad, Z., 2003. Effects of crocus sativus petals’ extract on rat blood pressure and on responses induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig ileum. Journal of ethnopharmacology, 84 (2-3), 199–203.
  • Fernandes, S.M., et al., 2016. The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats. Archives of endocrinology and metabolism, 60 (5), 443–449.
  • Fioretto, P., Caramori, M.L., and Mauer, M., 2008. The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007. Diabetologia, 51 (8), 1347–1355.
  • Frøssing, S., et al., 2018. Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS. Endocrine connections, 7 (1), 115–123.
  • Gilbert, R.E., and Cooper, M.E., 1999. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney international, 56 (5), 1627–1637.
  • Ginsberg, H.N., 2000. Insulin resistance and cardiovascular disease. The journal of clinical investigation, 106 (4), 453–458.
  • Golpon, H.A., et al., 2001. Vasorelaxant effect of glucagon-like peptide-(7-36) amide and amylin on the pulmonary circulation of the rat. Regulatory peptides, 102 (2-3), 81–86.
  • Guo, W., et al., 2014. The inhibitory effect of quercetin on asymmetric dimethylarginine-induced apoptosis is mediated by the endoplasmic reticulum stress pathway in glomerular endothelial cells. International journal of molecular sciences, 15 (1), 484–503.
  • Guruharsha, K.G., Kankel, M.W., and Artavanis-Tsakonas, S., 2012. The notch signalling system: recent insights into the complexity of a conserved pathway. Nature reviews genetics, 13 (9), 654–666.
  • Haneda, M., et al.,; Joint Committee on Diabetic Nephropathy. 2015. A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy. Journal of diabetes investigation, 6 (2), 242–246.
  • Hazman, Ö., and Bozkurt, M.F., 2015. Anti-inflammatory and antioxidative activities of safranal in the reduction of renal dysfunction and damage that occur in diabetic nephropathy. Inflammation, 38 (4), 1537–1545.
  • Imenshahidi, M., Hosseinzadeh, H., and Javadpour, Y., 2010. Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytotherapy research, 24 (7), 990–994.
  • Irvine, R.J., White, J., and Chan, R., 1997. The influence of restraint on blood pressure in the rat. Journal of pharmacological and toxicological methods, 38 (3), 157–162.
  • Kapucu, A., 2020. Crocin ameliorates oxidative stress and suppresses renal damage in streptozotocin induced diabetic male rats. Biotechnic and histochemistry., Aug 24, 1–8. Epub ahead of print. PMID: 32835521.
  • Kaur, N., Kishore, L., and Singh, R., 2017. Therapeutic effect of Linum usitatissimum L. in STZ-nicotinamide induced diabetic nephropathy via inhibition of AGE's and oxidative stress. Journal of food science and technology, 54 (2), 408–421.
  • Kianbakht, S., and Hajiaghaee, R., 2011. Anti-hyperglycemic effects of saffron and its active constituents, crocin and safranal, in alloxan-induced diabetic rats. Journal of medicinal plants, 3 (39), 82–89.
  • Kodera, R., et al., 2011. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia, 54 (4), 965–978.
  • Li, S., et al., 2017. Crocin protects podocytes against oxidative stress and inflammation induced by high glucose through inhibition of NF-κB. Cellular physiology and biochemistry, 42 (4), 1481–1492.
  • Liu, X., et al., 2018. Notch1 regulates PTEN expression to exacerbate renal tubulointerstitial fibrosis in diabetic nephropathy by inhibiting autophagy via interactions with Hes1. Biochemical and biophysical research communications, 497 (4), 1110–1116.
  • Lotfy, M., et al., 2014. Mechanism of the beneficial and protective effects of exenatide in diabetic rats. The journal of endocrinology, 220 (3), 291–304.
  • Mahdavifard, S., et al., 2016. The synergistic effect of antiglycating agents (MB-92) on inhibition of protein glycation, misfolding and diabetic complications in diabetic-atherosclerotic rat. European journal of medicinal chemistry, 121, 892–902. Oct 4 Epub 2015 Dec 18. PMID: 26733359.
  • Mahmoudzadeh, L., et al., 2017. Anti-inflammatory and protective effects of saffron extract in ischaemia/reperfusion-induced acute kidney injury. Nephrology (Carlton, Vic.).), 22 (10), 748–754.
  • Montgomery, H., and Dymock, J.F., 1961. Determination of nitrite in water. Analyst, 86 (102), 414.
  • Morsy, M.A., et al., 2014. Carvedilol ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Biomed research international, 2014, 105214
  • Mortensen, A., and Lykkesfeldt, J., 2014. Does vitamin C enhance nitric oxide bioavailability in a tetrahydrobiopterin-dependent manner? In vitro, in vivo and clinical studies. Nitric oxide: biology and chemistry, 36, 51–57.
  • Niranjan, T., Murea, M., and Susztak, K., 2009. The pathogenic role of notch activation in podocytes. Nephron experimental nephrology, 111 (4), e73–e79.
  • Ojima, A., et al., 2013. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product–induced protein arginine methyltranferase-1 expression. The American journal of pathology, 182 (1), 132–141.
  • Okoduwa, S.I.R., et al., 2017. Appropriate insulin level in selecting fortified diet-fed, streptozotocin-treated rat model of type 2 diabetes for anti-diabetic studies. PloS One, 12 (1), e0170971.
  • Østerby, R., et al., 1990. Glomerular structure and function in diabetic nephropathy: Early to advanced stages. Diabetes, 39 (9), 1057–1063.
  • Ozaki, N., et al., 2000. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol, 2 (11), 805–811.
  • Pavenstadt, H., Kriz, W., and Kretzler, M., 2003. Cell biology of the glomerular podocyte. Physiological reviews, 83 (1), 253–307.
  • Prabhakar, S.S., 2004. Role of nitric oxide in diabetic nephropathy. Seminars in nephrology, 24 (4), 333–344.
  • Reiniger, N., et al., 2010. Deletion of the receptor for advanced glycation endproducts reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes, 59 (8), 2043–2054.
  • Samarghandian, S., Azimi-Nezhad, M., and Samini, F., 2014. Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus. Biomed research international, 2014, 1–12.
  • Sancar-Bas, S., Gezginci-Oktayoglu, S., and Bolkent, S., 2015. Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice. Growth factors (Chur, Switzerland)), 33 (5-6), 419–429.
  • Segarra, M., et al., 2008. Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. Blood, 112 (5), 1904–1911.
  • Shirali, S., Zahra Bathaie, S., and Nakhjavani, M., 2013. Effect of crocin on the insulin resistance and lipid profile of streptozotocin‐induced diabetic rats. Phytotherapy research, 27 (7), 1042–1047.
  • Skov, J., et al., 2013. Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men. The journal of clinical endocrinology and metabolism, 98 (4), E664–E671.
  • Thomson, S.C., Kashkouli, A., and Singh, P., 2013. Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat. American journal of physiology. renal physiology, 304 (2), F137–F144.
  • Trinder, E., 1975. Instrument for the on-line measurement of the slow phase of nystagmus. Aviation, space, and environmental medicine, 46 (4 Sec 1), 441–444.
  • Velho, G., et al., 2013. Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes care, 36 (11), 3639–3645.
  • White, K.E., et al., 2002. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes, 51 (10), 3083–3089.
  • Wu, H., et al., 2016. Effects of exenatide therapy on insulin resistance in the skeletal muscles of high-fat diet and low-dose streptozotocin-induced diabetic rats. Endocrine research, 41 (1), 1–7.
  • Wu, H., et al., 2014. The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp. Journal of diabetes research, 2014, 1–10.
  • Xi, L., et al., 2007. Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes. British journal of pharmacology, 151 (5), 610–617.
  • Xiang, M., et al., 2006. Crocetin inhibits leukocyte adherence to vascular endothelial cells induced by AGEs. Journal of ethnopharmacology, 107 (1), 25–31.
  • Yamagishi, S.I., and Matsui, T., 2011. Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy-Friend or foe? Pharmacological research, 64 (3), 187–194.
  • Yan, S.F., et al., 2003. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circulation research, 93 (12), 1159–1169.
  • Yoon, C.H., et al., 2016. Diabetes-induced jagged1 overexpression in endothelial cells causes retinal capillary regression in a murine model of diabetes mellitus: insights into diabetic retinopathy. Circulation, 134 (3), 233–247.
  • Yosri, H., et al., 2017. Crocin modulates IL-4/IL-13 signaling and ameliorates experimentally induced allergic airway asthma in a murine model. International immunopharmacology, 50, 305–312.
  • Youn, J.Y., Park, H.Y., and Cho, K.H., 2004. Anti-hyperglycemic activity of Commelina communis L.: inhibition of α-glucosidase. Diabetes research and clinical practice, 66, S149–S155.
  • Yu, M., et al., 2003. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats. Journal of hypertension, 21 (6), 1125–1135.
  • Začiragić, A., et al., 2014. An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus. Bosnian journal of basic medical sciences, 14 (1), 21–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.